Data from Phase 3 REGENERATE study supporting positive benefit-risk profile of obeticholic acid (OCA) in liver fibrosis due to NASH to be featured in late-breaker podium presentation Analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results